There are 6 stocks that both hedge funds and mutual funds have as overweight — and SpaceX is one
Goldman Sachs identified six stocks, including SpaceX (SPCX), Boeing (BA), Capital One (COF), Mastercard (MA), Thermo Fisher (TMO), and Visa (V), that are overweighted by both hedge funds and mutual funds. These stocks have outperformed the S&P 500 by 29% this year, according to Goldman's analysis. SpaceX trades at 93 times next year's estimated earnings and is a dominant player in reusable rockets and satellite internet.
How this was made

The 30-second read
Why it matters
The list underscores sector preferences but offers no immediate catalyst for price moves.
Market read
Useful for sector rotation and fund‑flow strategies, but limited actionable insight.
What to watch
Potential regulatory or macro risks could offset fund buying pressure.
Background
Goldman Sachs analyzed 13‑F filings to identify six stocks both hedge funds and mutual funds hold overweight.
Ticker impact
Goldman analysis shows Boeing is one of six stocks overweight by both hedge funds and mutual funds.
Modest upside if fund allocations persist.
Fund overweight indicates confidence but no new catalyst.
Capital One appears in Goldman’s list of six overweight stocks for hedge funds and mutual funds.
Slight positive pressure.
Weighting reflects sector bias, not a fresh event.
Mastercard is identified as an overweight holding by both hedge funds and mutual funds.
Limited upside.
Overweight status is a data point, not a catalyst.
Thermo Fisher Scientific is listed among the six stocks both fund types overweight.
Minor positive effect.
No immediate catalyst beyond fund allocation data.
Visa is part of Goldman’s six-stock overweight list for hedge funds and mutual funds.
Modest upside potential.
Weighting reflects sector confidence, not a new event.
Market effects
Highlights fund bias toward financials, aerospace, and payments sectors.
U.S. equities may see modest support from fund allocations.
Limited to investors tracking fund positioning.
Counterpoint
Fund overweight does not guarantee outperformance; valuation premiums may be unjustified.
Key entities
- Research FirmGoldman Sachs
Provider of the fund positioning analysis.





